1. Home
  2. TEVA vs AER Comparison

TEVA vs AER Comparison

Compare TEVA & AER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • AER
  • Stock Information
  • Founded
  • TEVA 1901
  • AER 1995
  • Country
  • TEVA Israel
  • AER Ireland
  • Employees
  • TEVA N/A
  • AER N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • AER Diversified Commercial Services
  • Sector
  • TEVA Health Care
  • AER Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • AER Nasdaq
  • Market Cap
  • TEVA 20.1B
  • AER 21.0B
  • IPO Year
  • TEVA N/A
  • AER 2006
  • Fundamental
  • Price
  • TEVA $16.05
  • AER $112.10
  • Analyst Decision
  • TEVA Strong Buy
  • AER Strong Buy
  • Analyst Count
  • TEVA 7
  • AER 8
  • Target Price
  • TEVA $24.71
  • AER $123.00
  • AVG Volume (30 Days)
  • TEVA 9.9M
  • AER 1.1M
  • Earning Date
  • TEVA 07-30-2025
  • AER 07-30-2025
  • Dividend Yield
  • TEVA N/A
  • AER 0.96%
  • EPS Growth
  • TEVA N/A
  • AER N/A
  • EPS
  • TEVA N/A
  • AER 11.21
  • Revenue
  • TEVA $16,616,000,000.00
  • AER $8,055,588,000.00
  • Revenue This Year
  • TEVA $5.69
  • AER $3.27
  • Revenue Next Year
  • TEVA N/A
  • AER $1.96
  • P/E Ratio
  • TEVA N/A
  • AER $10.15
  • Revenue Growth
  • TEVA 3.82
  • AER 4.17
  • 52 Week Low
  • TEVA $12.47
  • AER $82.21
  • 52 Week High
  • TEVA $22.80
  • AER $118.07
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 40.10
  • AER 38.77
  • Support Level
  • TEVA $15.82
  • AER $113.80
  • Resistance Level
  • TEVA $16.74
  • AER $116.07
  • Average True Range (ATR)
  • TEVA 0.38
  • AER 1.82
  • MACD
  • TEVA -0.08
  • AER -0.47
  • Stochastic Oscillator
  • TEVA 15.54
  • AER 8.52

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.

Share on Social Networks: